Genematrix (XKRX:109820) FCF Margin % : 7.15% (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Genematrix FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genematrix's Free Cash Flow for the three months ended in Mar. 2024 was ₩129 Mil. Genematrix's Revenue for the three months ended in Mar. 2024 was ₩1,806 Mil. Therefore, Genematrix's FCF Margin % for the quarter that ended in Mar. 2024 was 7.15%.

As of today, Genematrix's current FCF Yield % is -2.89%.

The historical rank and industry rank for Genematrix's FCF Margin % or its related term are showing as below:

XKRX:109820' s FCF Margin % Range Over the Past 10 Years
Min: -65.35 Med: -19.11 Max: 26.03
Current: -15.34

During the past 13 years, the highest FCF Margin % of Genematrix was 26.03%. The lowest was -65.35%. And the median was -19.11%.

XKRX:109820's FCF Margin % is ranked worse than
53.6% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.255 vs XKRX:109820: -15.34

Genematrix FCF Margin % Historical Data

The historical data trend for Genematrix's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genematrix FCF Margin % Chart

Genematrix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-48.90

26.03

25.70

-10.67

-25.54

Genematrix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-41.61	-18.74	15.17	-53.12	7.15

Competitive Comparison of Genematrix's FCF Margin %

For the Diagnostics & Research subindustry, Genematrix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genematrix's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genematrix's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Genematrix's FCF Margin % falls into.

Genematrix FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Genematrix's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2506.99	/	9814.503
	=	-25.54 %

Genematrix's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	129.122	/	1805.894
	=	7.15 %

Genematrix FCF Margin % Related Terms

Thank you for viewing the detailed overview of Genematrix's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genematrix (XKRX:109820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genematrix Inc (XKRX:109820) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

700, Daewangpangyo-ro, Bundang-gu, Gyeonggi-do,694-1, Sampyeong-dong, Korea Bio Park B dong 8th floor, 463-400, Seongnam-si, KOR, 463-400

Website

http://www.genematrix.net

Genematrix Inc is a biotech company engaged in the development of the platform and molecular diagnostics products. Its products include NeoPlexTM STI-7 Detection kit, OmniPlex-HPV, PapilloTyper, HepB Typer-Adefovir, and HepB Typer-Precore among others.

Genematrix (XKRX:109820) Headlines

No Headlines